Logo image
Gender differences in use of prescription narcotic medications among living kidney donors
Journal article   Peer reviewed

Gender differences in use of prescription narcotic medications among living kidney donors

Krista L. Lentine, Ngan N. Lam, Mark A. Schnitzler, Amit X. Garg, Huiling Xiao, Sheila E. Leander, Daniel C. Brennan, Sandra J. Taler, David Axelrod and Dorry L. Segev
Clinical transplantation, Vol.29(10), pp.927-937
10/01/2015
DOI: 10.1111/ctr.12599
PMCID: PMC4805522
PMID: 26227016
url
https://www.ncbi.nlm.nih.gov/pmc/articles/4805522View
Open Access

Abstract

Prescription narcotic use among living kidney donors is not well described. Using a unique database that integrates national registry identifiers for living kidney donors (1987-2007) in the United States with billing claims from a private health insurer (2000-2007), we identified pharmacy fills for prescription narcotic medications in periods 1-4 and >4yr post-donation and estimated relative likelihoods of post-donation narcotic use by Cox regression. We also compared narcotic fill rates and medication possession ratios (MPRs, defined as (days of medication supplied)/(days observed)), between donors and age- and sex-matched non-donors. Overall, rates of narcotic medication fills were 32.3 and 32.4 per 100 person-years in periods 1-4 and >4yr post-donation. After age and race adjustment, women were approximately twice as likely as men to fill a narcotic prescription in years 1-4 (adjusted hazard ratio, aHR, 2.28; 95% confidence interval, CI, 1.86-2.79) and >4yr (aHR 1.70; 95% CI 1.50-1.93). MPRs in donors were low (<2.5% days exposed), and lower than among age- and sex-matched non-donors. Prescription narcotic medication use is more common among women than men in the intermediate term after live kidney donation. Overall, total narcotic exposure is low, and lower than among non-donors from the general population.
Surgery Life Sciences & Biomedicine Science & Technology Transplantation

Details

Metrics

Logo image